Frequency Therapeutics (FREQ) R&D Event

Frequency Therapeutics (FREQ) R&D Event

November 9, 2021

Frequency Therapeutics (FREQ) hosted a virtual R&D event on Tuesday, November 9th, 2021. The program included an update on advances for the Company’s FX-322 program for sensorineural hearing loss, as well as new potential restorative treatment programs for hearing loss and remyelination in multiple sclerosis.